Ravi Amaravadi

Ravi Amaravadi

University of Pennsylvania

H-index: 78

North America-United States

About Ravi Amaravadi

Ravi Amaravadi, With an exceptional h-index of 78 and a recent h-index of 66 (since 2020), a distinguished researcher at University of Pennsylvania,

His recent articles reflect a diverse array of research interests and contributions to the field:

Corrigendum to'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma':[Annals of Oncology …

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

Targeting UGCG overcomes resistance to lysosomal autophagy inhibition

579-C Reinvigoration of progenitor-exhausted CD8 T cells by anti-CTLA-4 contributes to the sustained activity of combination checkpoint blockade

Five-year survival outcomes in patients with melanoma with complete response to immunotherapy who discontinue therapy.

Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity

Patient-derived melanoma organoid models facilitate the assessment of immunotherapies

Ravi Amaravadi Information

University

Position

___

Citations(all)

46396

Citations(since 2020)

25702

Cited By

28934

hIndex(all)

78

hIndex(since 2020)

66

i10Index(all)

154

i10Index(since 2020)

130

Email

University Profile Page

University of Pennsylvania

Google Scholar

View Google Scholar Profile

Top articles of Ravi Amaravadi

Title

Journal

Author(s)

Publication Date

Corrigendum to'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma':[Annals of Oncology …

Annals of oncology: official journal of the European Society for Medical Oncology

CE Sharon

GN Tortorello

KL Ma

AC Huang

X Xu

...

2024/4/13

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature communications

Cathrine Axfors

Andreas M Schmitt

Perrine Janiaud

Janneke van’t Hooft

Sherief Abd-Elsalam

...

2024/2/5

FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

Clinical Cancer Research

Thomas M Anderson

Bryan H Chang

Alexander C Huang

Xiaowei Xu

Daniel Yoon

...

2024/1/24

Targeting UGCG overcomes resistance to lysosomal autophagy inhibition

Cancer discovery

Vaibhav Jain

Sandra L Harper

Amanda M Versace

Dylan Fingerman

Gregory Schuyler Brown

...

2023/2/6

579-C Reinvigoration of progenitor-exhausted CD8 T cells by anti-CTLA-4 contributes to the sustained activity of combination checkpoint blockade

Kevin Wang

Paulina Coutifaris

David Brocks

Sabrina Solis

Nicholas Han

...

2023/11/1

Five-year survival outcomes in patients with melanoma with complete response to immunotherapy who discontinue therapy.

Benjamin Aaron Bleiberg

Phyllis A Gimotty

Alex Mathew

Grayce Selig

Ahron Flowers

...

2023/6/1

Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity

Cell reports

Wenqun Zhong

Youtao Lu

Xuexiang Han

Jingbo Yang

Zhiyuan Qin

...

2023/10/31

Patient-derived melanoma organoid models facilitate the assessment of immunotherapies

EBioMedicine

Lingling Ou

Shujing Liu

Huaishan Wang

Yeye Guo

Lei Guan

...

2023/6/1

Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma

Annals of Oncology

CE Sharon

GN Tortorello

KL Ma

AC Huang

X Xu

...

2023/9/1

Phase I trial of autologous RNA-electroporated cMET-directed CAR T cells administered intravenously in patients with melanoma and breast carcinoma

Cancer Research Communications

Payal D Shah

Alexander C Huang

Xiaowei Xu

Robert Orlowski

Ravi K Amaravadi

...

2023/5/9

Lysosomal lipid peroxidation regulates tumor immunity

The Journal of Clinical Investigation

Monika Bhardwaj

Jennifer J Lee

Amanda M Versace

Sandra L Harper

Aaron R Goldman

...

2023/4/17

HRS mediates tumor immune evasion by regulating proteostasis-associated interferon pathway activation

Cell reports

Wei Zhang

Jiegang Yang

Beike Wang

Youtao Lu

Jingbo Yang

...

2023/11/28

A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer

The Oncologist

Charu Aggarwal

Alisha P Maity

Joshua M Bauml

Qi Long

Tomas Aleman

...

2023/7/1

Recent advances in targeting autophagy in cancer

Vaibhav Jain

Mahendra Pal Singh

Ravi K Amaravadi

2023/3/15

20th Anniversary of the Society for Melanoma Research: Celebrating two decades of progress in melanoma research

Ravi Amaravadi

Andrew Aplin

Meenhard Herlyn

Sheri Holmen

Richard White

...

2023/11

Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials

Hwanhee Hong

Anne Friedland

Mengyi Hu

Kevin J Anstrom

Susan Halabi

...

2023/6/1

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant …

Clinical Cancer Research

Janice M Mehnert

Tara C Mitchell

Alexander C Huang

Tomas S Aleman

Benjamin J Kim

...

2022/3/15

Pumping iron: ferritinophagy promotes survival and therapy resistance in pancreatic cancer

Cancer discovery

Vaibhav Jain

Ravi K Amaravadi

2022/9/2

HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors

Nature communications

Lei Guan

Bin Wu

Ting Li

Lynn A Beer

Gaurav Sharma

...

2022/7/14

Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers

Immunity

Josephine R Giles

Sasikanth Manne

Elizabeth Freilich

Derek A Oldridge

Amy E Baxter

...

2022/3/8

See List of Professors in Ravi Amaravadi University(University of Pennsylvania)